Provided by Tiger Trade Technology Pte. Ltd.

Beta Bionics, Inc.

18.87
-0.1100-0.58%
Post-market: 18.61-0.2600-1.38%19:30 EDT
Volume:1.14M
Turnover:21.54M
Market Cap:840.88M
PE:-11.45
High:19.44
Open:19.35
Low:18.39
Close:18.98
52wk High:32.71
52wk Low:8.80
Shares:44.56M
Float Shares:26.52M
Volume Ratio:0.97
T/O Rate:4.29%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6486
EPS(LYR):-1.8100
ROE:-26.16%
ROA:-16.67%
PB:3.28
PE(LYR):-10.43

Loading ...

Press Release: Beta Bionics Announces Second Quarter 2026 Financial Results and Updates Full Year 2026 Guidance

Dow Jones
·
Jul 30

Beta Bionics Coverage Assumed by UBS at Buy

Dow Jones
·
Jul 29

UBS Adjusts Price Target on Beta Bionics to $22 From $24, Maintains Buy Rating

MT Newswires Live
·
Jul 28

Beta Bionics resumed with a Buy at UBS

TIPRANKS
·
Jul 28

Here's Why We're Not Too Worried About Beta Bionics' (NASDAQ:BBNX) Cash Burn Situation

Simply Wall St.
·
Jul 28

Beta Bionics is Maintained at Buy by Goldman Sachs

Dow Jones
·
Jul 16

Beta Bionics is Maintained at Buy by Truist Securities

Dow Jones
·
Jul 14

Beta Bionics price target raised to $22 from $18 at Truist

TIPRANKS
·
Jul 13

Truist Raises Price Target on Beta Bionics to $22 From $18, Keeps Buy Rating

MT Newswires Live
·
Jul 13

Beta Bionics Schedules Q2 2026 Results Webcast and Conference Call

Reuters
·
Jul 01

Beta Bionics CFO Stephen Feider Disposes of USD 173,083.32 in Common Shares

Reuters
·
Jul 01

Beta Bionics Director Christy Jones Sells 1,406 Shares for $21,090

Reuters
·
Jun 26

Beta Bionics Chief Commercial Officer Mark Hopman disposes of 275 common shares for $3,385.25

Reuters
·
Jun 06

Beta Bionics director Christy Jones sells 2,811 shares worth $39,354

Reuters
·
Jun 06

Beta Bionics management to meet with Piper Sandler

TIPRANKS
·
Jun 04

Beta Bionics launches public near real-time real-world iLet Bionic Pancreas outcomes dashboard

Reuters
·
Jun 02

Beta Bionics First in Automated Insulin Delivery to Publish Near Real-Time Real-World Data on a Public Website

GlobeNewswire
·
Jun 02

Beta Bionics Is Maintained at Buy by Goldman Sachs

Dow Jones
·
May 28

Beta Bionics director Christy Jones disposes of 1,998 common shares worth $19,880.1

Reuters
·
May 27

Beta Bionics director Adam Lezack sells 1,998 common shares for $21,112.58

Reuters
·
May 27